Tech Transfer eNews Blog

Start-up focused on treating nerve damage enters Cornell incubator


By Jesse Schwartz
Published: January 15th, 2020

Renerva, a medical start-up focused on treating nerve damage, has joined Cornell University’s McGovern Center life sciences incubator.

Renerva is developing an injectable gel known as the Peripheral Nerve Matrix that accelerates the healing of damaged nerves. The start-up, which was formed concurrently at Cornell and the University of Pittsburgh, is also working on an off-the-shelf nerve graft technology that could spare patients from permanent disability.

“Other technology has focused on the late stages of nerve healing,” says Jonathan Cheetham, associate professor in the College of Veterinary Medicine at Cornell. “What we’re doing is trying to influence the early part of nerve healing that may lead to improved nerve function outcomes for patients down the road.”

Lou Walcer, director of the McGovern Center, comments, “Renerva epitomizes the research nature of Cornell. The company uses university research and technology, and it is extending that technology to help patients alleviate problems and pain. This is quite exciting.”

Renerva has received a total of more than $2.4 million in funding from the U.S. Department of Defense, the National Science Foundation and the National Institutes of Health. The start-up plans to enter the Peripheral Nerve Matrix into clinical trials this year.

Source: Cornell Chronicle

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment